Z-0200-2027 Class II Ongoing

Recalled by Greiner Bio-One North America, Inc. — Monroe, NC

FDA device recall Z-0200-2027 was initiated by Greiner Bio-One North America, Inc. on Jul 29, 2026 and is designated Class II. Reason for recall: Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++)… The recall status is ongoing. Affected quantity: 860450.

Recall details

Product Type
Devices
Report Date
Oct 28, 2026
Initiation Date
Jul 29, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
860450

Product description

Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator Model/Catalog Number: 454008P Product Description: Greiner VACUETTE Blood Collection Tube with Lithium Heparin and Gel Separator (13 x 75 mm, 3.5ml)

Reason for recall

Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++) results which have the potential to cause hyperkalemia.

Distribution pattern

U.S. Nationwide distribution in the states of CO, FL, IL, MO, NE, NY, OH, PA, and VA.

Code information

Lot Code: Item Number: 454008P Lot Number: B26043FM UDI: Rack: 29120017579032, Case: 39120017579039 Expiration Date: 2027-07-12

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0200-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0200-2027. Report a data issue: hello@regdatalab.com.